AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
This Quarter Return
-10.91%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$820M
AUM Growth
+$820M
(-24%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
98.94%
Holding
14
New
–
Increased
–
Reduced
4
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$13.9M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$5.2M |
| 3 |
Dianthus Therapeutics
DNTH
|
$2.11M |
| 4 |
Spero Therapeutics
SPRO
|
$101K |
| 5 |
Dyne Therapeutics
DYN
|
$18.4K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$2.95B
| $197M | 24.03% |
4,896,462
| – | – |
|
|
2
Dyne Therapeutics
DYN
$1.92B
| $189M | 23.05% |
8,019,354
-782
| -0% | -$18.4K |
|
3
Disc Medicine
IRON
$2.07B
| $159M | 19.41% |
2,509,456
| – | – |
|
|
THRD
4
DELISTED
Third Harmonic Bio
THRD
| $107M | 13.06% |
10,402,286
-505,573
| -5% | -$5.2M |
|
5
Day One Biopharmaceuticals
DAWN
$769M
| $81.5M | 9.94% |
6,430,257
| – | – |
|
6
Korro Bio
KRRO
$217M
| $43.3M | 5.28% |
1,137,149
| – | – |
|
|
VIGL
7
DELISTED
Vigil Neuroscience
VIGL
| $9.92M | 1.21% |
5,836,874
| – | – |
|
8
Generation Bio
GBIO
$40.4M
| $8.78M | 1.07% |
8,279,484
| – | – |
|
|
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
| $8.23M | 1% |
5,018,178
| – | – |
|
10
Q32 Bio
QTTB
$20.9M
| $7.2M | 0.88% |
2,092,106
| – | – |
|
|
JBIO
11
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $4.77M | 0.58% |
1,799,232
| – | – |
|
|
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $3.62M | 0.44% |
78,447
-300,000
| -79% | -$13.9M |
|
|
13
Spero Therapeutics
SPRO
$116M
| $314K | 0.04% |
305,255
-97,630
| -24% | -$101K |
|
|
14
Dianthus Therapeutics
DNTH
$759M
| – | – |
-76,979
| Closed | -$2.11M |
|